Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling.

Bone remodeling occurs asynchronously at multiple sites in the adult skeleton and involves resorption by osteoclasts, followed by formation of new bone by osteoblasts. Disruptions in bone remodeling contribute to the pathogenesis of disorders such as osteoporosis, osteoarthritis, and Paget's disease. Interactions among cells of osteoblast and osteoclast lineages are critical in the regulation of bone remodeling. We constructed a mathematical model of autocrine and paracrine interactions among osteoblasts and osteoclasts that allowed us to calculate cell population dynamics and changes in bone mass at a discrete site of bone remodeling. The model predicted different modes of dynamic behavior: a single remodeling cycle in response to an external stimulus, a series of internally regulated cycles of bone remodeling, or unstable behavior similar to pathological bone remodeling in Paget's disease. Parametric analysis demonstrated that the mode of dynamic behavior in the system depends strongly on the regulation of osteoclasts by autocrine factors, such as transforming growth factor beta. Moreover, simulations demonstrated that nonlinear dynamics of the system may explain the differing effects of immunosuppressants on bone remodeling in vitro and in vivo. In conclusion, the mathematical model revealed that interactions among osteoblasts and osteoclasts result in complex, nonlinear system behavior, which cannot be deduced from studies of each cell type alone. The model will be useful in future studies assessing the impact of cytokines, growth factors, and potential therapies on the overall process of remodeling in normal bone and in pathological conditions such as osteoporosis and Paget's disease.

[1]  W. Fraser,et al.  A Detailed Assessment of Alterations in Bone Turnover, Calcium Homeostasis, and Bone Density in Normal Pregnancy , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  K Yano,et al.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. de Vernejoul,et al.  Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. , 1991, Endocrinology.

[4]  Frost Hm,et al.  The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987 .

[5]  Philippe Orcel,et al.  Cyclosporin a induces in vivo inhibition of resorption and stimulation of formation in rat bone , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  E. Siris Paget's Disease of Bone , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  Z. Jaworski,et al.  Kinetics of osteoclasts and their nuclei in evolving secondary Haversian systems. , 1981, Journal of anatomy.

[8]  L. Raisz Physiology and pathophysiology of bone remodeling. , 1999, Clinical chemistry.

[9]  S. Ralston,et al.  Cytokine and growth factor expression in Paget's disease: analysis by reverse-transcription/polymerase chain reaction. , 1994, British journal of rheumatology.

[10]  A. Parfitt Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. , 2002, Bone.

[11]  M A Savageau,et al.  The tricarboxylic acid cycle in Dictyostelium discoideum. III. Analysis of steady state and dynamic behavior. , 1992, The Journal of biological chemistry.

[12]  M. Savageau Biochemical Systems Analysis: A Study of Function and Design in Molecular Biology , 1976 .

[13]  D B Burr,et al.  Targeted and nontargeted remodeling. , 2002, Bone.

[14]  C. H. Turner,et al.  Toward a Mathematical Description of Bone Biology: The Principle of Cellular Accommodation , 1999, Calcified Tissue International.

[15]  K. F. Tipton,et al.  Biochemical systems analysis: A study of function and design in molecular biology , 1978 .

[16]  S. Komarova,et al.  A possible role of adenylate metabolism in human erythrocytes: simple mathematical model. , 1996, Journal of theoretical biology.

[17]  M. Noor,et al.  Paget’s disease of bone: Diagnosis and treatment update , 2000, Current rheumatology reports.

[18]  H. Frost,et al.  The mechanostat: a proposed pathogenic mechanism of osteoporoses and the bone mass effects of mechanical and nonmechanical agents. , 1987, Bone and mineral.

[19]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[20]  Frost Hm,et al.  Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's law: the remodeling problem. , 1990 .

[21]  N Loveridge,et al.  Osteocyte density in aging subjects is enhanced in bone adjacent to remodeling haversian systems. , 2002, Bone.

[22]  L. Hofbauer,et al.  Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology , 2001, Journal of Molecular Medicine.

[23]  M H Kroll,et al.  Parathyroid hormone temporal effects on bone formation and resorption , 2000, Bulletin of mathematical biology.

[24]  S. Epstein,et al.  Cyclosporin A in the oophorectomized rat: Unexpected severe bone resorption , 1989, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  R. Derynck,et al.  Osteoblastic Responses to TGF-β during Bone Remodeling , 1998 .

[26]  A. Frausto,et al.  Cytokines Expressed in Multinucleated Cells: Paget's Disease and Giant Cell Tumors versus Normal Bone , 1997, Calcified Tissue International.

[27]  H. Frost,et al.  Skeletal structural adaptations to mechanical usage (SATMU): 1. Redefining Wolff's Law: The bone modeling problem , 1990, The Anatomical record.

[28]  B. Martin,et al.  Mathematical model for repair of fatigue damage and stress fracture in osteonal bone , 1995, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[29]  M. Horton,et al.  Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. , 2001, Bone.

[30]  A. Parfitt Osteonal and hemi‐osteonal remodeling: The spatial and temporal framework for signal traffic in adult human bone , 1994, Journal of cellular biochemistry.

[31]  Hisataka Yasuda,et al.  Transforming Growth Factor β Affects Osteoclast Differentiation via Direct and Indirect Actions , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.